Related Experiment Video
Updated: Apr 11, 2026
07:51
A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
Published on: June 18, 2018
11.3K
D2 autoreceptors gate vulnerability to cocaine use disorder
Erin M Murray1, Daniel Diaz-Urbina2, Roland Bock1,2,3
1NIAAA, National Institutes of Health, Bethesda, MD 20892.
Biorxiv : the Preprint Server for Biology
|April 10, 2026
Summary
Identifying biomarkers for addiction vulnerability is crucial. This study reveals that dopamine D2/3 receptor changes in specific neuron types influence cocaine-seeking behavior, suggesting D1 and D2/3 receptor balance as a key indicator.
Area of Science:
- Neuroscience
- Addiction Research
- Molecular Biology
Background:
- Substance use disorder (SUD) is complex, as not all drug use leads to addiction, necessitating biomarkers for vulnerability.
- Reduced striatal dopamine D2/3 receptor availability is linked to stimulant use, but it conflates presynaptic and postsynaptic contributions.
- Dissociating these receptor roles is vital for understanding addiction mechanisms.
Purpose of the Study:
- To differentiate the roles of presynaptic (autoreceptor) and postsynaptic (heteroreceptor) dopamine D2/3 receptors in addiction vulnerability.
- To investigate how cell-type-specific reductions in dopamine D2/3 receptors affect cocaine-seeking behavior and adaptation.
- To identify potential biomarkers for addiction vulnerability based on dopamine receptor balance.
Main Methods:
- Utilized cell type-specific *Drd2* haploinsufficiency models in mice: dopamine neurons (autoD2KD) and medium spiny neurons (MSN-D2KD).
- Assessed changes in dopamine release, phasic gain, and cocaine-evoked dopamine signaling.
- Examined behavioral responses to cocaine, sucrose, and punishment, alongside striatal D2/3 and D1 receptor binding.
Main Results:
- Autoreceptor haploinsufficiency (autoD2KD) impaired presynaptic dopamine control, enhanced dopamine release, and prolonged cocaine-induced dopamine elevations.
- autoD2KD mice exhibited increased exploratory behavior and heightened cocaine-seeking, despite normal responses to reward and punishment.
- Different genotypes showed distinct D1-like compensations, leading to varied striatal D1:D2/3 receptor ratios.
Conclusions:
- Presynaptic dopamine D2 autoreceptors play a critical role in regulating dopamine release and adaptation to cocaine.
- Striatal D1 receptor density and the D1:D2/3 receptor balance may serve as crucial biomarkers to distinguish addiction vulnerability.
- Understanding cell-type-specific dopamine receptor function is essential for developing targeted interventions for SUD.
Related Concept Videos
01:15Drug Abuse and Addiction: Pharmacological Phenomena
1.6K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.6K
01:20Desensitization and Tachyphylaxis
3.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.4K
01:29Drugs Affecting Neurotransmitter Synthesis
2.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.6K
01:17Drug Dependence
2.0K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
2.0K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.9K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.9K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
4.9K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.9K